IL146544A0 - Microbial polynucleotides expressed during infection of a host - Google Patents

Microbial polynucleotides expressed during infection of a host

Info

Publication number
IL146544A0
IL146544A0 IL14654400A IL14654400A IL146544A0 IL 146544 A0 IL146544 A0 IL 146544A0 IL 14654400 A IL14654400 A IL 14654400A IL 14654400 A IL14654400 A IL 14654400A IL 146544 A0 IL146544 A0 IL 146544A0
Authority
IL
Israel
Prior art keywords
antigens
infection
expressed
microbial
during
Prior art date
Application number
IL14654400A
Other languages
English (en)
Original Assignee
Ivigene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivigene Corp filed Critical Ivigene Corp
Publication of IL146544A0 publication Critical patent/IL146544A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL14654400A 1999-08-06 2000-08-04 Microbial polynucleotides expressed during infection of a host IL146544A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14755199P 1999-08-06 1999-08-06
PCT/US2000/021340 WO2001011081A2 (en) 1999-08-06 2000-08-04 Microbial polynucleotides expressed during infection of a host

Publications (1)

Publication Number Publication Date
IL146544A0 true IL146544A0 (en) 2002-07-25

Family

ID=22522023

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14654400A IL146544A0 (en) 1999-08-06 2000-08-04 Microbial polynucleotides expressed during infection of a host
IL146544A IL146544A (en) 1999-08-06 2001-11-18 Method of identifying a polynucleotide of a microbe that is expressed in vivo

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146544A IL146544A (en) 1999-08-06 2001-11-18 Method of identifying a polynucleotide of a microbe that is expressed in vivo

Country Status (13)

Country Link
US (1) US8034571B1 (xx)
EP (1) EP1238102B1 (xx)
AT (1) ATE414172T1 (xx)
AU (1) AU778821B2 (xx)
CA (1) CA2374156C (xx)
DE (2) DE1238102T1 (xx)
DK (1) DK1238102T3 (xx)
ES (1) ES2184659T1 (xx)
HK (1) HK1050029B (xx)
IL (2) IL146544A0 (xx)
MX (1) MXPA01012787A (xx)
NZ (2) NZ531589A (xx)
WO (1) WO2001011081A2 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720139B1 (en) 1999-01-27 2004-04-13 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in Escherichia coli
US7033748B2 (en) * 1999-08-06 2006-04-25 Ivigene Corporation Identification of microbial polynucleotides expressed during infection of a host
AU778821B2 (en) 1999-08-06 2004-12-23 Oragenics, Inc. Microbial polynucleotides expressed during infection of a host
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
US7052860B2 (en) 2001-11-28 2006-05-30 University Of Florida Research Foundation Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
JP2006519586A (ja) * 2002-11-20 2006-08-31 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド 歯周疾患の診断、治療、およびモニタリングのためのアクチノバチルス・アクチノミセテムコミタンス抗原の同定
CA2504930A1 (en) * 2002-11-20 2004-06-03 University Of Florida Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
DK1660524T3 (da) 2003-08-15 2011-05-09 Univ Florida Identifikation af porphyromonas gingivalis virulens polynukleotider til diagnose, behandling, og monitorering af periodontale sygdomme
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789157A (en) * 1990-06-11 1998-08-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue selex
US20040247611A1 (en) 1994-05-23 2004-12-09 Montana State University Identification of pathogen-ligand interactions
US6013443A (en) * 1995-05-03 2000-01-11 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue SELEX
US6048527A (en) 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions
WO1998030910A1 (en) * 1997-01-09 1998-07-16 Whitehead Institute For Biomedical Research Subtractive antibody screening (sas) and uses therefor
CA2286335C (en) * 1997-04-15 2007-02-27 Barnes-Jewish Hospital Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies
US6040144A (en) * 1997-07-25 2000-03-21 Mount Sinai School Of Medicine Procedure for preparing gene expression libraries enriched for secretory protein genes
AU9395398A (en) * 1997-09-19 1999-04-12 Chiron Corporation Subtractive protein screening for gene identification
US6514694B2 (en) * 1997-12-19 2003-02-04 Heska Corporation Methods for the detection of encysted parasites
AU778821B2 (en) 1999-08-06 2004-12-23 Oragenics, Inc. Microbial polynucleotides expressed during infection of a host

Also Published As

Publication number Publication date
HK1050029B (zh) 2009-03-27
IL146544A (en) 2008-11-26
EP1238102A2 (en) 2002-09-11
MXPA01012787A (es) 2005-08-26
CA2374156A1 (en) 2001-02-15
ES2184659T1 (es) 2003-04-16
DE60040804D1 (de) 2008-12-24
WO2001011081A3 (en) 2002-07-11
NZ531589A (en) 2005-08-26
AU6519700A (en) 2001-03-05
ATE414172T1 (de) 2008-11-15
US8034571B1 (en) 2011-10-11
NZ515553A (en) 2005-01-28
AU778821B2 (en) 2004-12-23
DE1238102T1 (de) 2003-05-28
DK1238102T3 (da) 2009-02-09
CA2374156C (en) 2008-01-29
EP1238102B1 (en) 2008-11-12
HK1050029A1 (en) 2003-06-06
WO2001011081A2 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
MY125202A (en) Vaccine
CA2201587A1 (en) Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
EP1731166A3 (en) Streptococcus pneumoniae proteins and vaccines
MXPA01011047A (es) Secuencias genomicas de neisseria y metodos para su uso.
IL146544A0 (en) Microbial polynucleotides expressed during infection of a host
MX9707061A (es) Proteina con superficie resistente de proteinase k de neisseria meningitidis.
NZ330887A (en) Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
NZ512574A (en) Novel streptococcus antigens useful as vaccines
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
MX349481B (es) Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
RU2006105498A (ru) Полипептиды для индукции защитного иммунного ответа против staphylococcus aureus
DE69941574D1 (de) Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n-acryloyliertem polysaccharid
CA2224127A1 (en) Flagellin gene, flac of campylobacter
WO2002004496A3 (en) Fimh adhesin proteins and methods of use
WO1998045328A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
EP0831900A4 (en) METHOD FOR TRAINING ANTIBODIES AGAINST E. CS4CFA / 1 FAMILY PACKAGE
EA200100700A1 (ru) Гены и белки и их применение
PT1154791E (pt) Composições e métodos de vacinação contra neisseria
WO2003044161A3 (en) Gene amplification and overexpression in cancer
YU22202A (sh) Vakcina
MXPA01010186A (es) Composiciones y metodos para el tratamiento y diagnostico de cancer de mama.
WO2004015063A3 (en) Amplification and overexpression of oncogenes
WO2004112575A3 (en) Gene amplification and overexpression in cancer
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
CN101659959B (zh) 一种人重组角蛋白19抗原活性片段表达载体及其应用

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed